Nicholas A Morris1,2, Alexander E Merkler3,4, Whitney E Parker5, Jan Claassen3, E Sander Connolly6, Kevin N Sheth7, Hooman Kamel4,8. 1. Department of Neurology, Columbia College of Physicians and Surgeons, New York, NY, USA. nam2185@cumc.columbia.edu. 2. Department of Neurology, Weill Cornell Medical College, New York, NY, USA. nam2185@cumc.columbia.edu. 3. Department of Neurology, Columbia College of Physicians and Surgeons, New York, NY, USA. 4. Department of Neurology, Weill Cornell Medical College, New York, NY, USA. 5. Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, USA. 6. Department of Neurological Surgery, Columbia College of Physicians and Surgeons, New York, NY, USA. 7. Departments of Neurology and Neurosurgery, Yale School of Medicine, New Haven, CT, USA. 8. Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY, USA.
Abstract
BACKGROUND: Little is known about the natural history of non-surgically managed subdural hematoma (SDH). The purpose of this study is to determine rates of adverse events after non-surgical management of SDH and whether these outcomes differ depending on traumatic versus nontraumatic etiology. A retrospective cohort study was conducted using administrative claims data on all emergency department visits and acute care hospitalizations at nonfederal facilities in California from 2005 to 2011, Florida from 2005 to 2012, and New York from 2006 to 2011. We included patients who were discharged home after hospitalization with a first-recorded diagnosis of SDH and no record of surgical hematoma evacuation. METHODS: Patients were followed for readmission with SDH, readmission for surgical SDH evacuation, and fatal readmission with SDH. Survival statistics and the log-rank test were used to compare rates of these adverse events after traumatic versus nontraumatic SDH. Multivariable Cox regression analysis was used to compare hazards for traumatic versus nontraumatic etiology while adjusting for age, sex, race, insurance status, presence of dementia, alcohol use, acquired abnormalities in coagulation, acquired abnormalities in platelet function, hypertension, atrial fibrillation, venous thromboembolism, ischemic stroke, coronary heart disease, and valvular disease. RESULTS: We identified 27,502 conservatively treated patients with SDH, of which 70.9% were traumatic and 29.1% nontraumatic. Compared to patients with traumatic SDH, patients with nontraumatic SDH had significantly higher rates of subsequent hospitalization with SDH (cumulative 90-day rates: 15.3 % [95% CI 14.5-16.1%] vs. 10.3% [95% CI 9.9-10.8%]), surgical SDH evacuation (7.8% [95% CI 7.3-8.5%] vs. 5.5% [95% CI 5.2-5.8%]), and SDH-related in-hospital death (1.0% [95% CI 0.8-1.2%] vs. 0.4% [95 % CI 0.3-0.5%]). In multivariable Cox regression analysis, nontraumatic etiology was associated with a higher hazard of readmission with SDH (HR 1.4; 95% CI 1.3-1.5), surgery (HR 1.3; 95% CI 1.2-1.4), and in-hospital mortality (HR 1.9; 95% CI 1.4-2.5). Our findings were unchanged in sensitivity analyses that also adjusted for Elixhauser comorbidities. CONCLUSIONS: Approximately one in eight patients with a conservatively managed SDH was readmitted with SDH within 90 days. A substantial proportion of these readmissions involved surgical hematoma evacuation. These outcomes occurred significantly more often after nontraumatic as compared to traumatic SDH.
BACKGROUND: Little is known about the natural history of non-surgically managed subdural hematoma (SDH). The purpose of this study is to determine rates of adverse events after non-surgical management of SDH and whether these outcomes differ depending on traumatic versus nontraumatic etiology. A retrospective cohort study was conducted using administrative claims data on all emergency department visits and acute care hospitalizations at nonfederal facilities in California from 2005 to 2011, Florida from 2005 to 2012, and New York from 2006 to 2011. We included patients who were discharged home after hospitalization with a first-recorded diagnosis of SDH and no record of surgical hematoma evacuation. METHODS:Patients were followed for readmission with SDH, readmission for surgical SDH evacuation, and fatal readmission with SDH. Survival statistics and the log-rank test were used to compare rates of these adverse events after traumatic versus nontraumatic SDH. Multivariable Cox regression analysis was used to compare hazards for traumatic versus nontraumatic etiology while adjusting for age, sex, race, insurance status, presence of dementia, alcohol use, acquired abnormalities in coagulation, acquired abnormalities in platelet function, hypertension, atrial fibrillation, venous thromboembolism, ischemic stroke, coronary heart disease, and valvular disease. RESULTS: We identified 27,502 conservatively treated patients with SDH, of which 70.9% were traumatic and 29.1% nontraumatic. Compared to patients with traumatic SDH, patients with nontraumatic SDH had significantly higher rates of subsequent hospitalization with SDH (cumulative 90-day rates: 15.3 % [95% CI 14.5-16.1%] vs. 10.3% [95% CI 9.9-10.8%]), surgical SDH evacuation (7.8% [95% CI 7.3-8.5%] vs. 5.5% [95% CI 5.2-5.8%]), and SDH-related in-hospital death (1.0% [95% CI 0.8-1.2%] vs. 0.4% [95 % CI 0.3-0.5%]). In multivariable Cox regression analysis, nontraumatic etiology was associated with a higher hazard of readmission with SDH (HR 1.4; 95% CI 1.3-1.5), surgery (HR 1.3; 95% CI 1.2-1.4), and in-hospital mortality (HR 1.9; 95% CI 1.4-2.5). Our findings were unchanged in sensitivity analyses that also adjusted for Elixhauser comorbidities. CONCLUSIONS: Approximately one in eight patients with a conservatively managed SDH was readmitted with SDH within 90 days. A substantial proportion of these readmissions involved surgical hematoma evacuation. These outcomes occurred significantly more often after nontraumatic as compared to traumatic SDH.
Authors: M A Croce; D L Dent; P G Menke; J T Robertson; M S Hinson; B H Young; T B Donovan; F E Pritchard; G Minard; K A Kudsk Journal: J Trauma Date: 1994-06
Authors: Ali Seifi; Ali Akbar Asadi-Pooya; Kevin Carr; Mitchell Maltenfort; Mehrdad Emami; Rodney Bell; Michael Moussouttas; Moussa Yazbeck; Fred Rincon Journal: Springerplus Date: 2014-07-01
Authors: Alexandra S Reynolds; Monica L Chen; Alexander E Merkler; Abhinaba Chatterjee; Iván Díaz; Babak B Navi; Hooman Kamel Journal: Cerebrovasc Dis Date: 2019-08-21 Impact factor: 2.762
Authors: Santosh B Murthy; Ajay Gupta; Alexander E Merkler; Babak B Navi; Pitchaiah Mandava; Costantino Iadecola; Kevin N Sheth; Daniel F Hanley; Wendy C Ziai; Hooman Kamel Journal: Stroke Date: 2017-04-17 Impact factor: 7.914
Authors: Santosh B Murthy; Xian Wu; Ivan Diaz; Melvin Parasram; Neal S Parikh; Costantino Iadecola; Alexander E Merkler; Guido J Falcone; Stacy Brown; Alessandro Biffi; Judy Ch'ang; Jared Knopman; Philip E Stieg; Babak B Navi; Kevin N Sheth; Hooman Kamel Journal: Stroke Date: 2020-03-17 Impact factor: 7.914
Authors: Stacy C Brown; Zachary A King; Lindsey Kuohn; Hooman Kamel; Emily J Gilmore; Jennifer A Frontera; Santosh Murthy; Jennifer A Kim; Sacit Bulent Omay; Guido J Falcone; Kevin N Sheth Journal: Neurology Date: 2020-09-09 Impact factor: 11.800
Authors: Martin Vychopen; Motaz Hamed; Majd Bahna; Attila Racz; Inja Ilic; Abdallah Salemdawod; Matthias Schneider; Felix Lehmann; Lars Eichhorn; Christian Bode; Andreas H Jacobs; Charlotte Behning; Patrick Schuss; Erdem Güresir; Hartmut Vatter; Valeri Borger Journal: Brain Sci Date: 2022-07-26